1-14 of 14
A Sureda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Waldenström’s Macroglobulinemia.

Charalampia Kyriakou, MD, C. Canals, MD, A. Sureda, MD, G. Taghipour, C. Gisselbrecht, MD, P. Mazza, MD, E. Montserrat, MD, N. Niederwieser, MD, K. Indrak, MD, A. Kolbe, MD, P. Biron, MD, A. Levis, MD, A. Goldstone, MD, N. Schmitz, MD
Journal: Blood
Blood (2007) 110 (11): 941.
https://doi.org/10.1182/blood.V110.11.941.941
Published: 2007
Journal Articles

Allogeneic Stem Cell Transplantation in Angioimmunoblastic T-Cell Lymphoma (AITL): A Retrospective Survey from the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).

Charalampia Kyriakou, MD, C. Canals, MD, G. Taghipour, J. Finke, MD, H. Kolb, MD, A. Goldstone, MD, A. Sureda, MD, N. Schmitz, MD
Journal: Blood
Blood (2007) 110 (11): 3042.
https://doi.org/10.1182/blood.V110.11.3042.3042
Published: 2007
Journal Articles

Non Myeloablative Allogeneic Related Transplant in Patients with Aggressive B Cell Lymphoma: Results of Two Multicenter Spanish Trials. The GELTAMO Group.

M.D. Caballero, J. Briones, M.V Mateos, J.F. Tomás, R. Martino, J. de la Serna, J.L. Díez, J.A. Pérez-Simón, A. Sureda, J. Sarrá, J. García-Laraña, J.M. Ribera, J. Sierra, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 5053.
https://doi.org/10.1182/blood.V110.11.5053.5053
Published: 2007
Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) in the Management of Advanced Waldenstrom’s Macroglobulinemia (WM).

Charalampia Kyriakou, MD, C. Canals, MD, A. Sureda, MD, G. Taghipour, J. Cornelissen, MD, R. Willemze, MD, G. Socie, MD, H. Greinix, MD, J. Kienast, MD, R. Hamladji, MD, M. Kazmi, MD, P. Jacobs, MD, N. Schmitz, MD
Journal: Blood
Blood (2007) 110 (11): 619.
https://doi.org/10.1182/blood.V110.11.619.619
Published: 2007
Journal Articles

Feasibility and Efficacy of a Planned Second Transplant (“auto” or “mini-allo”) Intensification in Patients with Multiple Myeloma (MM) Not Achieving Complete Remission (CR) or Near-CR with a First Autologous Transplant. Results from a Spanish PETHEMA/GEM Study.

L. Rosiñol, J. J. Lahuerta, A. Sureda, J. de la Rubia, J. García-Laraña, M. Hernández-García, B. Hernández-Ruíz, J. A. Pérez-Simón, J. L. Bello, D. Carrera, M. J. Peñarrubia, E. Abella, A. León, C. Poderós, J. C. García-Ruíz, J. Besalduch, R. Martínez-Martínez, I. Pérez-Fernández, P. Ribas, F. Escalante, J. San Miguel, J. Bladé.
Journal: Blood
Blood (2005) 106 (11): 425.
https://doi.org/10.1182/blood.V106.11.425.425
Published: 2005
Journal Articles

Epidemiology of Multiple Myeloma in Spain: An Analytic Review.

A. Alegre, F. Lara, R. Gabriel, B. Aguado, L.M. Sánchez, S. Damiano, J. San Miguel, J. Blade, J.J. Lahuerta, A. Sureda, J. García-Laraña, J. Díaz Mediavilla, F. de Arriba, J. de la Rubia, F. Prosper, J. Bargay, R. Martínez, C. Martinez-Chamorro, M.T. Hernández, F. Hernández-Navarro, J. Besalduch, M. González-López, J. Petit, C. Solano, L. Hernández-Nieto, J. Baro, R. Parody, R. Cabrera, E. Flores, M.T. Bernal, J.F. Tomás, J.M. Fernández-Rañada
Journal: Blood
Blood (2005) 106 (11): 5089.
https://doi.org/10.1182/blood.V106.11.5089.5089
Published: 2005
Journal Articles

Reduced Intensity Conditioning Unrelated Transplant Plus Cyclosporine and MMF as GVHD Prophylaxis: Results of a Prospective Study.

J.A. Perez-Simon, MD, PhD, R. Martino, MD, PhD, R. de la Camara, MD, PhD, J. Perez de Oteiza, MD, PhD, J.M. Moraleda, MD, PhD, M. Diez-Campelo, MD, PhD, A. Sureda, MD, PhD, A. Alegre, MD, PhD, J. Sierra, MD, PhD, J.F. San Miguel, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5312.
https://doi.org/10.1182/blood.V106.11.5312.5312
Published: 2005
Journal Articles

A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma (MM) Patients.

M.V. Mateos, M. Hernández, J. Díaz Mediavilla, L. Palomera, M.J. Moro, J. Hernández, J.J. Lahuerta, J. De la Rubia, M.J. Terol, A. Sureda, J. Bargay, F. Arriba, A. Alegre, P. Rivas, J. García-Laraña, J.M. Ribera, D. Carrera, J. Bladé, F. Prósper, D.L. Esseltine, H. van de Velde, D. Schenkein, J.F. San Miguel
Journal: Blood
Blood (2005) 106 (11): 786.
https://doi.org/10.1182/blood.V106.11.786.786
Published: 2005
Journal Articles

High-Dose Therapy/Stem Cell Support (HDT), Including Tandem Transplant, for Primary Refractory Multiple Myeloma (MM): Results from the Spanish Myeloma Group (PETHEMA/GEM) in 49 Patients.

L. Rosinol, R. Garcia-Sanz, J. J. Lahuerta, M. Hernandez-Garcia, A. Sureda, J. de la Rubia, J. M. Ribera, B. Hernandez-Ruiz, D. Carreras, I. Navarro, J. C. Garcia-Ruiz, S. Gardella, J. Garcia-Larana, J. Diaz-Mediavilla, J. F. San Miguel, J. Blade
Journal: Blood
Blood (2005) 106 (11): 5472.
https://doi.org/10.1182/blood.V106.11.5472.5472
Published: 2005
Journal Articles

Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma.

G. Mateo, PhD, M. Castellanos, A. Rasillo, N. C. Gutierrez, MDPhD, M. A. Montalban, M. L. Martin, J. M. Hernandez, MDPhD, M. C. Lopez-Berges, MDPhD, L. Monteiano, Joan Blade, MDPhD, M. V. Mateos, MDPhD, A. Sureda, MDPhD, J. Rubia, MD, J. Diaz-Mediavilla, MDPhD, J. J. Lahuerta, MD, A. Orfao, MDPhD, J.F. San Miguel, MDPhD
Journal: Blood
Blood (2004) 104 (11): 1425.
https://doi.org/10.1182/blood.V104.11.1425.1425
Published: 2004
Journal Articles

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

K. S. Peggs, A. Sureda, A. Hunter, M. D. Caballero, J. Cavet, A. Urbano-Ispizua, A. Parker, J. M. Ribera, P. Mahendra, M. A. Canales, D. Milligan, J. C. Hernandez-Boluda, E. C. Morris, I. Alvarez, A. H. Goldstone, D. C. Linch, J. Sierra, S. Mackinnon
Journal: Blood
Blood (2004) 104 (11): 807.
https://doi.org/10.1182/blood.V104.11.807.807
Published: 2004
Journal Articles

Influence of Age on Survival after a Tandem Hematopoietic Stem Cell Transplantation Procedure in Patients with Multiple Myeloma: Results of the Prospective GEM-2000 Protocol.

A. Sureda, J. Blade, J.J. Lahuerta, J. de la Rubia, R. Martinez, D. Carrera, J. Garcia-Laraña, A. Alegre, M. Hernandez, C. Rivas, J.M. Ribera, M.J. Peñarrubia, L. Palomera, F. Prosper, F. de Arriba, A. Leon, E. Abella, B. Hernandez-Ruiz, F. Casado, J.C. Garcia-Ruiz, J. Besalduch, F.J. Fernandez-Calvo, A. Touchard, J. San Miguel, for the Spanish Group of Multiple Myeloma (MM)
Journal: Blood
Blood (2004) 104 (11): 930.
https://doi.org/10.1182/blood.V104.11.930.930
Published: 2004
Journal Articles

A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma Patients.

M.V. Mateos, Joan Blade, J. Diaz Mediavilla, J.J. Lahuerta, M.J. Terol, J. Hernández, M.J. Moro, J. Bargay, J.M. Ribera, J. de la Rubia, A. Sureda, D. Carrera, F. de Arriba, L. Palomera, M. Hernández, J. García Laraña, A. Alegre, F. Prosper, P. Rivas, D.L. Esseltine, D. Schenkein, J.F. San Miguel
Journal: Blood
Blood (2004) 104 (11): 3462.
https://doi.org/10.1182/blood.V104.11.3462.3462
Published: 2004
Journal Articles

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

BB Bjorkstrand, P Ljungman, H Svensson, J Hermans, A Alegre, J Apperley, J Blade, K Carlson, M Cavo, A Ferrant, AH Goldstone, A de Laurenzi, I Majolino, R Marcus, HG Prentice, K Remes, D Samson, A Sureda, LF Verdonck, L Volin, G Gahrton
Journal: Blood
Blood (1996) 88 (12): 4711–4718.
https://doi.org/10.1182/blood.V88.12.4711.bloodjournal88124711
Published: 1996